EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AURKA Suppresses Ferroptosis via the KEAP1/NRF2/HO‑1 Axis in EGFR-Mutant Lung Adenocarcinoma

Yufeng Huang, Gengqiu Liu, Zhu Liang, Junhang Zhang

Frontiers in Bioscience-Landmark · 29.08.2025 · 30 (8)

DOI: 10.31083/fbl41293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 29.08.2025. Verfasst von Yufeng Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Seventh Affiliated Hospital, Sun Yat-Sen University, 518107 Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Kelch-Like ECH-Associated Protein 1, Aurora Kinase A. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Traditional Chinese Medicine Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adenocarcinoma of Lung (LUAD) remains a leading cause of cancer-related deaths across the globe, and patients harboring epidermal growth factor receptor (EGFR) mutations frequently develop resistance to targeted therapies. While aurora kinase A (AURKA) has been implicated in tumorigenesis, its involvement in regulating ferroptosis via the kelch-like ECH-associated protein 1 (KEAP1)/NF-E2-related factor 2 (NRF2)/heme oxygenase 1 (HO‑1) signaling axis in EGFR-mutant LUAD remains poorly understood.

Methods

We analyzed RNA-seq and clinical data from 594 LUAD samples from The Cancer Genome Atlas (TCGA) to explore associations between AURKA expression, EGFR mutation status, and immune cell infiltration. A ferroptosis-focused random forest algorithm was constructed to predict EGFR-mutant cases. In vitro, AURKA was silenced by siRNA in EGFR-mutant NCI-H1975 cells; subsequent assays included transcriptome profiling, measurements of intracellular Fe2⁺, malondialdehyde (MDA), glutathione (GSH), mitochondrial reactive oxygen species (ROS) levels, and ultrastructural examination by electron microscopy. Protein levels of NRF2, HO‑1, solute carrier family 7 member 11 (SLC7A11), glutathione peroxidase 4 (GPX4), and KEAP1 were assessed via western blot.

Results

The ferroptosis gene–based random forest model distinguished EGFR-mutant LUAD with an area under the curve (AUC) of 0.84. Clinically, high AURKA expression was significantly associated with EGFR wild-type status (p = 0.035), reduced overall survival (p = 0.011), increased M1 macrophage infiltration, and decreased CD4⁺ T-cell infiltration. AURKA knockdown triggered hallmark features of ferroptosis—iron overload (p < 0.001), elevated MDA levels (p < 0.01), increased lipid peroxidation (p < 0.05), heightened mitochondrial ROS (p < 0.05), reduced mitochondrial membrane potential, GSH depletion (p < 0.05), and disruption of mitochondrial cristae. Mechanistically, loss of AURKA decreased KEAP1 (p < 0.01) and enhanced NRF2 (p < 0.001) and HO-1 (p < 0.01) and NRF2 nuclear translocation, while downregulating SLC7A11 (p < 0.05) and GPX4 (p < 0.01). Cell cycle analysis revealed G1-phase arrest (p < 0.001).

Conclusions

Our findings demonstrate that AURKA promotes ferroptosis resistance in EGFR-mutant LUAD by modulating the KEAP1/NRF2/HO-1 axis. Notably, this effect was validated in the gefitinib-resistant EGFR T790M-mutant NCI-H1975 cell model. Our results highlight AURKA as a potential therapeutic target for overcoming epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance and suggest that disrupting the AURKA/KEAP1/NRF2/HO‑1 pathway may offer a novel strategy for treating EGFR-mutant LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1Aurora Kinase AAdenocarcinoma of LungLung NeoplasmsHeme Oxygenase-1AdenocarcinomaHumansErbB ReceptorsMutationCell Line, TumorSignal TransductionFemaleGene Expression Regulation, NeoplasticMale

Stichwörter der Autor:innen

Aurora kinase AErbB receptorsNF-E2-related factor 2adenocarcinoma of lungferroptosis

Substanzen

NF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1Aurora Kinase AErbB ReceptorsKEAP1 protein, humanNFE2L2 protein, humanEGFR protein, humanAURKA protein, humanHeme Oxygenase-1HMOX1 protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Seventh Affiliated Hospital, Sun Yat-Sen University, 518107 Shenzhen, Guangdong, China.
  • Department of Cardiothoracic Surgery, Affiliated Hospital of Guangdong Medical University, 524000 Zhanjiang, Guangdong, China.

Förderung

  • Guangdong Traditional Chinese Medicine Project

Zitieren

APA

Huang, Y., Liu, G., Liang, Z., & Zhang, J. (2025). AURKA Suppresses Ferroptosis via the KEAP1/NRF2/HO‑1 Axis in EGFR-Mutant Lung Adenocarcinoma. Frontiers in Bioscience-Landmark, 30(8). https://doi.org/10.31083/fbl41293

Vancouver

Huang Y, Liu G, Liang Z, Zhang J. AURKA Suppresses Ferroptosis via the KEAP1/NRF2/HO‑1 Axis in EGFR-Mutant Lung Adenocarcinoma. Frontiers in Bioscience-Landmark. 2025;30(8). doi:10.31083/fbl41293

BibTeX
@article{Huang2025,
  author = {Huang, Yufeng and Liu, Gengqiu and Liang, Zhu and Zhang, Junhang},
  title = {AURKA Suppresses Ferroptosis via the KEAP1/NRF2/HO‑1 Axis in EGFR-Mutant Lung Adenocarcinoma},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  volume = {30},
  number = {8},
  doi = {10.31083/fbl41293}
}
Kostenlos starten →